{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:29:43Z","timestamp":1786552183389,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ejmech.2014.06.035","type":"journal-article","created":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T00:16:52Z","timestamp":1403050612000},"page":"344-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Design and green synthesis of 2-(diarylalkyl)aminobenzothiazole derivatives and their dual activities as angiotensin converting enzyme inhibitors and calcium channel blockers"],"prefix":"10.1016","volume":"83","author":[{"given":"Praveen Kumar","family":"Kalavagunta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1206-1233","authenticated-orcid":false,"given":"Pankaj K.","family":"Bagul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anvesh","family":"Jallapally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Kantevari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1835-6537","authenticated-orcid":false,"given":"Narender","family":"Ravirala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2014.06.035_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.gheart.2012.01.005","article-title":"Policy depot: a tool to build global capacity in cardiovascular health policy","volume":"7","author":"Mason","year":"2012","journal-title":"Glob. Heart"},{"key":"10.1016\/j.ejmech.2014.06.035_bib2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrcardio.2011.157","article-title":"Current challenges in the clinical management of hypertension","volume":"9","author":"Ruilope","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejmech.2014.06.035_bib3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrcardio.2012.33","article-title":"Key advances in antihypertensive treatment","volume":"9","author":"Paulis","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejmech.2014.06.035_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/bmj.e7473","article-title":"Resistant hypertension","volume":"345","author":"Myat","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.ejmech.2014.06.035_bib5","unstructured":"http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG034NICEguideline.pdf (last date of access 09.07.13.)."},{"key":"10.1016\/j.ejmech.2014.06.035_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/psb.538","article-title":"ACE inhibitors: their properties and current role in hypertension","volume":"20","author":"Ooi","year":"2009","journal-title":"Prescriber"},{"key":"10.1016\/j.ejmech.2014.06.035_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/psb.38","article-title":"ACE inhibitors: their properties and role in hypertension","volume":"18","author":"Ooi","year":"2007","journal-title":"Prescriber"},{"key":"10.1016\/j.ejmech.2014.06.035_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.toxicon.2011.03.017","article-title":"From snake venom toxins to therapeutics \u2013 cardiovascular examples","volume":"59","author":"Koh","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.ejmech.2014.06.035_bib9","first-page":"9","article-title":"ACE inhibition as a cornerstone of hypertension treatment","volume":"31","author":"Laurent","year":"2009","journal-title":"Medicographica"},{"key":"10.1016\/j.ejmech.2014.06.035_bib10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1248\/bpb.26.1345","article-title":"Hypotensive effect of butein via the inhibition of angiotensin converting enzyme","volume":"26","author":"Kang","year":"2003","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2014.06.035_bib11","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.1021\/jf302445x","article-title":"Ethanolic extracts and isolated compounds from small-leaf grape (Vitisthunbergii var. taiwaniana) with antihypertensive activities","volume":"60","author":"Lin","year":"2012","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2014.06.035_bib12","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/np50052a017","article-title":"Inhibitory effects of various flavonoids isolated from leaves of Persimmon on angiotensin-converting enzyme activity","volume":"50","author":"Kameda","year":"1987","journal-title":"J.\u00a0Nat. products"},{"key":"10.1016\/j.ejmech.2014.06.035_bib13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1021\/np50083a025","article-title":"Inhibition of angiotensin-i-converting enzyme by tetrahydroxyxanthones isolated from Tripterospermum lanceolatum","volume":"55","author":"Chen","year":"1992","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2014.06.035_bib14","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1021\/jm070191h","article-title":"Novel vanilloid receptor-1 antagonists:\u2009 3. The identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic properties","volume":"50","author":"Wang","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.06.035_bib15","unstructured":"Japan Science and Technology Agency, Kyoto University, Nagoya City University, Pharma Frontier Co. Ltd. Patent, EP2151236 (2010)."},{"key":"10.1016\/j.ejmech.2014.06.035_bib16","unstructured":"Bernard, V., Florence, C., John, G., Bruno, L. Patent US2004\/127552 (2004)."},{"key":"10.1016\/j.ejmech.2014.06.035_bib17","unstructured":"Beth Israel Deaconess Medical Center, PatentWO2008\/67061 (2008)."},{"key":"10.1016\/j.ejmech.2014.06.035_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0028-3908(92)90173-M","article-title":"Flunarizine and R 56865 suppress veratridine-induced increase in oxygen consumption and uptake of 45Ca2+ in rat cortical synaptosomes","volume":"31","author":"Wermelskirchen","year":"1992","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2014.06.035_bib19","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1021\/jm980335f","article-title":"Novel calcium antagonists with both calcium overload inhibition and antioxidant activity. 1. 2-(3,5-Di-tert-butyl-4-hydroxyphenyl)-3-(aminopropyl)thiazolidinones","volume":"41","author":"Kato","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.06.035_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2007.10.023","article-title":"Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1","volume":"578","author":"Fumagalli","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.06.035_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.lfs.2007.10.015","article-title":"Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells","volume":"82","author":"Wang","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2014.06.035_bib22","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sj.bjp.0705491","article-title":"Riluzole inhibits spontaneous Ca2+ signaling in neuroendocrine cells by activation of K+ channels and inhibition of Na+ channels","volume":"140","author":"Beltran-Parrazal","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.06.035_bib23","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0022-3565(24)36931-9","article-title":"Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons","volume":"282","author":"Huang","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2014.06.035_bib24","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.1016\/j.tetlet.2007.08.042","article-title":"Water promoted one-pot synthesis of 2\u2032-aminobenzothiazolomethyl naphthols and 5-(2\u2032-aminobenzothiazolomethyl)-6-hydroxyquinolines","volume":"48","author":"Shaabani","year":"2007","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2014.06.035_bib25","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1071\/CH10209","article-title":"Sodium dodecyl sulphate-assisted synthesis of 1-(Benzothiazolylamino)methyl-2-napthols in water","volume":"63","author":"Kumar","year":"2010","journal-title":"Aust. J. Chem."},{"key":"10.1016\/j.ejmech.2014.06.035_bib26","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/10426507.2012.664221","article-title":"NaHSO4.H2O catalyzed multicomponent synthesis of 1-(Benzothiazolylamino)methyl-2-naphthols under solvent-free conditions","volume":"187","author":"Asghar","year":"2012","journal-title":"Phosphorus Sulfur Silicon Relat. Elem."},{"key":"10.1016\/j.ejmech.2014.06.035_bib27","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1016\/j.bmc.2013.05.031","article-title":"Design, synthesis and evaluation of novel 2-hydroxypyrrolobenzodiazepine-5,11-dione analogues as potent angiotensin converting enzyme (ACE) inhibitors","volume":"21","author":"Dinesh","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.06.035_bib28","doi-asserted-by":"crossref","first-page":"9388","DOI":"10.1021\/ac901775h","article-title":"Colorimetric, high-throughput assay for screening angiotensin i-converting enzyme inhibitors","volume":"81","author":"Jim sheena","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2014.06.035_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1537-1891(02)00311-7","article-title":"Vasorelaxant effects of eugenol on rat thoracic aorta","volume":"40","author":"Damiani","year":"2003","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.06.035_bib30","unstructured":"http:\/\/www.molegro.com\/mvd-product.php (last date of access 12.06.13.)."},{"key":"10.1016\/j.ejmech.2014.06.035_bib31","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/jm051197e","article-title":"MolDock: a new technique for high-accuracy molecular docking","volume":"49","author":"Thomsen","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.06.035_bib32","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2174\/092986712799034950","article-title":"Structure based drug design of angiotensin-I converting enzyme inhibitors","volume":"19","author":"Anthony","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.06.035_bib33","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrd1227","article-title":"ACE revisited: a new target for structure-based drug design","volume":"2","author":"Acharya","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2014.06.035_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0049493","article-title":"Inhibition of angiotensin-converting enzyme activity by flavonoids: structure-activity relationship studies","volume":"7","author":"Guerrero","year":"2012","journal-title":"PLoS One"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414005546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414005546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T10:58:20Z","timestamp":1746269900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523414005546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":34,"alternative-id":["S0223523414005546"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.06.035","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and green synthesis of 2-(diarylalkyl)aminobenzothiazole derivatives and their dual activities as angiotensin converting enzyme inhibitors and calcium channel blockers","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.06.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}